Search

Your search keyword '"Colonic Neoplasms metabolism"' showing total 197 results

Search Constraints

Start Over You searched for: Descriptor "Colonic Neoplasms metabolism" Remove constraint Descriptor: "Colonic Neoplasms metabolism" Journal cancer letters Remove constraint Journal: cancer letters
197 results on '"Colonic Neoplasms metabolism"'

Search Results

1. Circular RNA circHIPK2 inhibits colon cancer cells through miR-373-3p/RGMA axis.

2. Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis.

3. Gap junctions mediate glucose transfer to promote colon cancer growth in three-dimensional spheroid culture.

4. Elevated MMP10/13 mediated barrier disruption and NF-κB activation aggravate colitis and colon tumorigenesis in both individual or full miR-148/152 family knockout mice.

5. Non-bone metastatic cancers promote osteocyte-induced bone destruction.

6. Estrogen inhibits the growth of colon cancer in mice through reversing extracellular vesicle-mediated immunosuppressive tumor microenvironment.

7. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice.

8. Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells.

9. Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2.

10. Palmitic acid negatively regulates tumor suppressor PTEN through T366 phosphorylation and protein degradation.

11. A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity.

12. PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses.

13. IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells.

14. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.

15. Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells.

16. Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide.

17. Lemur tyrosine kinase 2 acts as a positive regulator of NF-κB activation and colon cancer cell proliferation.

18. Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction.

19. Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity.

20. Oncogenic PITX2 facilitates tumor cell drug resistance by inverse regulation of hOCT3/SLC22A3 and ABC drug transporters in colon and kidney cancers.

21. Targeted demethylation of the SARI promotor impairs colon tumour growth.

22. Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression.

23. Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.

24. Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.

25. Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

26. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.

27. Tannins from Syzygium guineense suppress Wnt signaling and proliferation of Wnt-dependent tumors through a direct effect on secreted Wnts.

28. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.

29. Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1.

30. Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile.

31. HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression.

32. Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.

33. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.

34. Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells.

35. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.

36. Epigenetic effects of inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer.

37. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.

38. The dopamine D 3 receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell lines.

39. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).

40. The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton.

41. High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.

42. Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.

43. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB.

44. Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer.

45. Distinct mechanisms for opposite functions of homeoproteins Cdx2 and HoxB7 in double-strand break DNA repair in colon cancer cells.

46. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.

47. The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil.

48. Thioredoxin-like protein 2b facilitates colon cancer cell proliferation and inhibits apoptosis via NF-κB pathway.

49. Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.

50. Two repeated low doses of doxorubicin are more effective than a single high dose against tumors overexpressing P-glycoprotein.

Catalog

Books, media, physical & digital resources